logo

XBIO

Xenetic BiosciencesยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

XBIO Profile

Xenetic Biosciences, Inc.

A biotech company that develops next-generation immunotherapies and targeted oncology therapies

Pharmaceutical
--
11/07/2016
NASDAQ Stock Exchange
2
12-31
Common stock
945 Concord Street, Framingham, Massachusetts 01701
--
Xenetic Biosciences, Inc., was founded in Nevada in August 2011. It is a clinical-stage biopharmaceutical company focused on the discovery, research and development of new generation biopharmaceuticals and novel orphan tumor treatments that may contribute to the improvement of human health worldwide.